Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Dow
UBS
Moodys
Argus Health
Queensland Health
McKinsey
Boehringer Ingelheim

Generated: November 15, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021366

« Back to Dashboard

NDA 021366 describes CRESTOR, which is a drug marketed by IPR and is included in one NDA. It is available from eleven suppliers. There are four patents protecting this drug and one Paragraph IV challenge. Additional details are available on the CRESTOR profile page.

The generic ingredient in CRESTOR is rosuvastatin calcium. There are forty-one drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.
Summary for 021366
Tradename:CRESTOR
Applicant:Ipr
Ingredient:rosuvastatin calcium
Patents:4
Formulation / Manufacturing:see details
Pharmacology for NDA: 021366
Medical Subject Heading (MeSH) Categories for 021366
Suppliers and Packaging for NDA: 021366
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CRESTOR rosuvastatin calcium TABLET;ORAL 021366 NDA AstraZeneca Pharmaceuticals LP 0310-0751 0310-0751-39 100 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (0310-0751-39)
CRESTOR rosuvastatin calcium TABLET;ORAL 021366 NDA AstraZeneca Pharmaceuticals LP 0310-0751 0310-0751-90 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-0751-90)

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Aug 12, 2003TE:ABRLD:Yes
Regulatory Exclusivity Expiration:May 27, 2023
Regulatory Exclusivity Use:AN ADJUNCT TO DIET TO REDUCE LDL-C, TOTAL-C, NONHDL-C AND APOB IN CHILDREN AND ADOLESCENTS 7 TO 17 YEARS OF AGE WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, EITHER ALONE OR WITH OTHER LIPID-LOWERING TREATMENTS (E.G., LDL APHERESIS)
Regulatory Exclusivity Expiration:Nov 20, 2018
Regulatory Exclusivity Use:NEW PATIENT POPULATION
Patent:➤ Try a Free TrialPatent Expiration:Feb 4, 2021Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021366

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ipr CRESTOR rosuvastatin calcium TABLET;ORAL 021366-004 Aug 12, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Ipr CRESTOR rosuvastatin calcium TABLET;ORAL 021366-003 Aug 12, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Ipr CRESTOR rosuvastatin calcium TABLET;ORAL 021366-005 Aug 12, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Ipr CRESTOR rosuvastatin calcium TABLET;ORAL 021366-002 Aug 12, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Ipr CRESTOR rosuvastatin calcium TABLET;ORAL 021366-003 Aug 12, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Ipr CRESTOR rosuvastatin calcium TABLET;ORAL 021366-004 Aug 12, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Ipr CRESTOR rosuvastatin calcium TABLET;ORAL 021366-003 Aug 12, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Argus Health
Farmers Insurance
Merck
McKinsey
Fuji
Accenture
Mallinckrodt
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.